tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ross Osborn, 56 are a BUY (88.89%), 7 are a HOLD (11.11%).
Analyst Ross Osborn works at CANTOR FITZGERALD with a stock forecast success ratio of 11.01% fulfilled within 25.79 days on average.
Ross Osbornās has documented 121 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ORGO, Organogenesis Holdings at 01-Mar-2024.
Analyst best performing recommendations are on NYXH (NYXOAH).
The best stock recommendation documented was for NNOX (NANO X IMAGINGĀ LTD) at 1/5/2023. The price target of $21 was fulfilled within 148 days with a profit of $13.58 (183.02%) receiving and performance score of 12.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
12
$8.55 (247.83%)
12.5
2 months 3 days ago
1/4 (25%)
$6.26 (109.06%)
109
Hold
4 months 6 days ago
3/3 (100%)
$-4.36 (-12.69%)
129
Hold
8
$4.55 (131.88%)
9
5 months 13 days ago
6/6 (100%)
$1.2 (17.65%)
156
Buy
15
$11.55 (334.78%)
17
5 months 19 days ago
5/9 (55.56%)
$8.82 (142.72%)
123
Buy
11
$7.55 (218.84%)
14
5 months 19 days ago
2/8 (25%)
$4.82 (77.99%)
16
Which stock is Ross Osborn is most bullish on?
Which stock is Ross Osborn is most reserved on?
What Year was the first public recommendation made by Ross Osborn?
